C
Cadrenal Therapeutics, Inc. (CVKD)
NCM – Real vaqt narxi. Valyuta: USD
5.19
-0.33 (-6.02%)
Yopilishda: May 12, 2026, 4:00 PM EDT
5.29
+0.10 (1.93%)
Bozordan keyin: May 12, 2026, 5:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
5.19
-0.33 (-6.02%)
Yopilishda: May 12, 2026, 4:00 PM EDT
5.29
+0.10 (1.93%)
Bozordan keyin: May 12, 2026, 5:59 PM EDT
Cadrenal Therapeutics, Inc. hayot uchun xavfli immunitet va trombotik kasalliklar uchun yangi davolash usullarini ishlab chiqadigan kechki bosqichdagi biofarmatsevtika kompaniyasi sifatida ishlaydi. Kompaniya surunkali antikoagulyatsiyani talab qiladigan bemorlarda, masalan, chap qorincha yordamchi qurilmalari, buyrak etishmovchiligining oxirgi bosqichi va atriyal fibrilatsiya bilan og'rigan bemorlarda qon quyqalaridan kelib chiqqan yurak xurujlari, insult va o'limni oldini olish uchun mo'ljallangan 3-bosqichli klinik sinovda bo'lgan og'iz orqali qabul qilinadigan K vitamini antagonistini, Tecarfarinni ishlab chiqmoqda; Heparin bilan indüklangan trombotsitopeniya, jiddiy immunitet vositachiligidagi trombotik kasallikni davolash uchun birinchi turdagi 12-LOX inhibitori bo'lgan CAD-1005, 2-bosqichli klinik sinovni yakunlagan; va Frunexian, shoshilinch kasalxona sharoitida foydalanish uchun mo'ljallangan parenteral klinik bosqichdagi XIa omil inhibitori, 1-bosqichli klinik sinovni yakunlagan. Kompaniya chap qorincha yordamchi qurilmasi bo'lgan bemorlarda Tecarfarinning samaradorligi va xavfsizligini baholash uchun Abbott Global Enterprises Limited bilan hamkorlik shartnomasiga ega. Kompaniya 2022 yilda tashkil etilgan va shtab-kvartirasi Ponte Vedra, Floridada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. James J. Ferguson FACC, M.D. | Chief Medical Officer |
| Dr. Matthew Boxer M.B.A., Ph.D. | Executive Vice President of Corporate Development |
| Mr. Jeffrey Cole | Chief Operating Officer |
| Mr. Quang X. Pham | Chairman & CEO |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | ea0289377-8k_cadrenal.htm |
| 2026-05-07 | 10-Q | ea0288837-10q_cadrenal.htm |
| 2026-04-30 | 8-K | ea0288376-8k_cadrenal.htm |
| 2026-04-21 | S-3 | ea0286431-s3_cadrenal.htm |
| 2026-04-06 | D | |
| 2026-03-31 | 8-K | ea0284258-8k_cadrenal.htm |
| 2026-03-31 | 10-K | ea0283741-10k_cadrenal.htm |
| 2026-03-12 | 8-K | ea0281315-8k_cadrenal.htm |
| 2026-02-24 | 8-K | ea0278072-8k_cadrenal.htm |
| 2025-12-31 | D |